Skip to main content
SpringerLink
Log in

Alopecia Areata

  • Chapter
Hair Growth and Disorders

  • 5559 Accesses

Abstract

• Alopecia areata (AA) is a reversible, initially patchy hair loss most commonly involving the scalp although other regions of the head, including eyelashes and beard, may also be affected. The disease may sometimes lead to complete baldness of the scalp (alopecia areata totalis) or of the entire body (alopecia areata universalis).

• The course of AA is usually characterized by phases of acute hair loss followed by spontaneous hair regrowth and waxing and waning of the lesions. However, in severe forms hair loss can persist for many years or even life.

• Typical nail changes of AA are pitting, transversal grooves, red spotted lunulae or trachyonychia.

• Histopathological features of AA include perifollicular and intrafollicular lymphocytic infiltrates involving only anagen hair follicles with subsequent miniaturization of these structures.

• Alopecia areata is regarded as a T-cell-mediated autoimmune disease of the hair follicle that is mediated by CD4+ and CD8+ T-lymphocytes. As with other autoimmune diseases, AA most likely has a polygenic character, where susceptibility is dictated by several major genes and the phenotype may be modified by numerous minor genes.

• The most effective treatment for severe AA is the application of a contact sensitizer, while limited AA can be treated by intralesional corticosteroids or clobetasol propionate 0.05% ointment under occlusion. Pulse therapy with systemic corticosteroids or psoralen UV A (PUVA) is often used but neither has yet been proven in controlled studies to be effective in AA.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 299.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Similar content being viewed by others

References

  1. Abell E, Munro DD (1973) Intralesional treatment of alopecia areata with triamcinolone acetonide by jet injector. Br J Dermatol 88:55–9.

    Article  PubMed  CAS  Google Scholar 

  2. Alsaleh QA, Nanda A, al-Hasawi F, el-Kashlan M (1995) Concurrent appearance of alopecia areata in siblings. Pediatr Dermatol 12:285–6.

    Article  PubMed  CAS  Google Scholar 

  3. Averbakh EV, Pospelov LE (1986) HLA antigens in patients with alopecia areata. Vestn Dermatol Venerol 1:24–6.

    PubMed  Google Scholar 

  4. Barahmani N, de Andrade M, Slusser JP, Zhang Q, Duvic M (2006) Major histocompatibility complex class I chain-related gene A polymorphisms and extended haplotypes are associated with familial alopecia areata. J Invest Dermatol 126(1):74–8.

    Article  PubMed  CAS  Google Scholar 

  5. Betterle C, Greggio NA, Volpato M (1998) Clinical review 93. Autoimmune polyglandular syndrome type 1. J Clin Endocrinol Metab 83:1049–55.

    Article  PubMed  Google Scholar 

  6. Blaumeiser B, van der Goot I, Fimmers R, Hanneken S, Ritzmann S, Seymons K, Betz RC, Ruzicka T, Wienker TF, De Weert J, Lambert J, Kruse R, Nothen MM (2006) Familial aggregation of alopecia areata. J Am Acad Dermatol 54(4):627–32.

    Article  PubMed  Google Scholar 

  7. Bystryn J-C, Tamesis J (1991) Immunological aspects of hair loss. J Invest Dermatol 96:88s–9s.

    Google Scholar 

  8. Carroll JM, McElwee KJ, King L, Byrne MC, Sundberg JP (2002) Gene array profiling and immunomodulation studies define a cell-mediated immune response underlying the pathogenesis of alopecia areata in a mouse model and humans. J Invest Dermatol 119:392–402.

    Article  PubMed  CAS  Google Scholar 

  9. Carter DM, Jegasothy BV (1976) Alopecia areata and Down syndrome. Arch Dermatol 112:1397–9.

    Article  PubMed  CAS  Google Scholar 

  10. Case PC, Mitchell AJ, Swanson NA, Vanderveen EE, Ellis CN, Headington JT (1984) Topical therapy of alopecia areata with squaric acid dibutylester. J Am Acad Dermatol 10:447–51.

    Article  PubMed  CAS  Google Scholar 

  11. Caserio RJ (1987) Treatment of alopecia areata with squaric acid dibutylester. Arch Dermatol 123:1036–41.

    Article  PubMed  CAS  Google Scholar 

  12. Colombe BW, Price VH, Khoury EL, Garovoy MR, Lou CD (1995) HLA class II antigen associations help to define two types of alopecia areata. J Am Acad Dermatol 33:757–64.

    PubMed  CAS  Google Scholar 

  13. Colon EA, Popkin MK, Callies AL, Dessert NJ, Hordinsky MK (1991) Lifetime prevalence of psychiatric disorders in patients with alopecia areata. Compr Psychiatry 32:245–51.

    Article  PubMed  CAS  Google Scholar 

  14. Cork MJ, Crane AM, Duff GW (1996) Genetic control of cytokines: cytokine gene polymorphisms in alopecia areata. Dermatol Clin 14:671–8.

    Article  PubMed  CAS  Google Scholar 

  15. Cotellessa C, Peris K, Caracciolo E, Mordenti C, Chimenti S (2001) The use of topical diphenylcyclopropenone for the treatment of extensive alopecia areata. J Am Acad Dermatol 44:73–6.

    Article  PubMed  CAS  Google Scholar 

  16. Du Vivier A, Munro DD (1975) Alopecia areata, autoimmunity, and Down’s syndrome. Br Med J I:191–2.

    Google Scholar 

  17. Duvic M, Hordinsky MK, Fiedler VC, O’Brien WR, Young R, Reveille JD (1991) HLA-D locus associations in alopecia areata. Arch Dermatol 127:64–8.

    Article  PubMed  CAS  Google Scholar 

  18. Eggefagh L, Neorost S, Mirmirani P (2004) Alopecia areata in a patient using infliximab: new insights into the role of tumor necrosis factor on human hair follicle. Arch Dermatol 140: 1012

    Google Scholar 

  19. Elenkov IJ, Chrousos GP (2002) Stress hormones, proinflammatory and anti-inflammatory cytokines, and autoimmunity. Ann N Y Acad Sci 966:290–303.

    PubMed  CAS  Google Scholar 

  20. Frentz G (1977) Topical treatment of extended alopecia. Dermatologica 155:147–54.

    PubMed  CAS  Google Scholar 

  21. Freyschmidt-Paul P, Hoffmann R, Levine E, Sundberg JP, Happle R, McElwee KJ (2001) Current and potential agents for the treatment of alopecia areata. Curr Pharm Des 7:213–30.

    Article  PubMed  CAS  Google Scholar 

  22. Freyschmidt-Paul P, Happle R, McElwee KJ, Hoffmann R (2003) Alopecia areata: treatment today and potential treatments of tomorrow. J Invest Dermatol Symp Proc 8:12–17.

    Article  Google Scholar 

  23. Freyschmidt-Paul P, McElwee K, Hoffmann R (2005) Alopecia areata. In: Hertl M (ed) Autoimmune diseases of the skin: pathogenesis, diagnosis, management. Springer, Berlin Heidelberg New York, pp 385–420.

    Chapter  Google Scholar 

  24. Fülöp E, Vajda Z (1971) Experimentelle Untersuchungen über die therapeutische und schädigende Wirkung der intrafokalen Steroidbehandlung. Dermatol Monatsschr 157:269–77.

    PubMed  Google Scholar 

  25. Galbraith GM, Pandey JP (1989) Km1 allotype association with one subgroup of alopecia areata. Am J Hum Genet 44:426–8.

    PubMed  CAS  Google Scholar 

  26. Galbraith GM, Pandey JP (1995) Tumor necrosis factor alpha (TNF-alpha) gene polymorphism in alopecia areata. Hum Genet 96:433–6.

    Article  PubMed  CAS  Google Scholar 

  27. Galbraith GM, Thiers BH, Pandey JP (1984) Gm allotype associated resistance and susceptibility to alopecia areata. Clin Exp Immunol 56:149–52.

    PubMed  CAS  Google Scholar 

  28. Galbraith GM, Palesch Y, Gore EA, Pandey JP (1999) Contribution of interleukin 1beta and KM loci to alopecia areata. Hum Hered 49:85–9.

    Article  PubMed  CAS  Google Scholar 

  29. Gilhar A, Pillar T, Assay B, David M (1992) Failure of passive transfer of serum from patients with alopecia areata and alopecia universalis to inhibit hair growth in transplants of human scalp skin grafted on to nude mice. Br J Dermatol 126:166–71.

    Article  PubMed  CAS  Google Scholar 

  30. Gilhar A, Landau M, Assy B, Shalaginov R, Serafimovich S, Kalish RS (2002) Mediation of alopecia areata by cooperation between CD4+ and CD8+ T lymphocytes: transfer to human scalp explants on Prkdc(scid) mice. Arch Dermatol 138:916–22.

    Article  PubMed  Google Scholar 

  31. Goldsmith LA (1991) Summary of alopecia areata research workshop and future research directions. J Invest Dermatol 96:98S–100S.

    PubMed  Google Scholar 

  32. Gordon PM, Aldridge RD, McVittie E, Hunter JAA (1996) Topical diphencyprone for alopecia areata: evaluation of 48 cases after 30 months’ follow up. Br J Dermatol 134:869–71.

    Article  PubMed  CAS  Google Scholar 

  33. Gundogan C, Greve B, Raulin C (2004) Treatment of alopecia areata with the 308-nm xenon chloride excimer laser: case report of two successful treatments with the excimer laser. Lasers Surg Med 34:86–90.

    Article  PubMed  Google Scholar 

  34. Happle R, Kalveram KJ, Büchner U, Echternacht-Happle K, Göggelmann W, Summer KH (1980) Contact allergy as a therapeutic tool for alopecia areata: application of squaric acid dibutylester. Dermatologica 161:289–97.

    PubMed  CAS  Google Scholar 

  35. Happle R, Hausen BM, Wiesner-Menzel L (1983) Diphencyprone in the treatment of alopecia areata. Acta Derm Venereol (Stockh) 63:49–52.

    CAS  Google Scholar 

  36. Happle R, Perret C, Wiesner-Menzel L (1984) Treatment of alopecia areata with diphencyprone induces hair regrowth and affects the composition of peribulbar infiltrates. In: MacDonald DM (ed) Immunodermatology. Butterworth, London, pp 279–86.

    Google Scholar 

  37. Herbst V, Zöller M, Kissling S, Wenzel E, Stutz N, Freyschmidt-Paul P (2006) Diphenylcyclopropenone treatment of alopecia areata induces apoptosis of perifollicular lymphocytes. Eur J Dermatol 15(5):537–42.

    Google Scholar 

  38. Hordinsky MK, Hallgren H, Nelson D, Filipovich AH (1984) Familial alopecia areata. HLA antigens and autoantibody formation in an American family. Arch Dermatol 120:464–8.

    PubMed  Google Scholar 

  39. Hoting E, Boehm A (1992) Therapy of alopecia areata with diphencyprone. Br J Dermatol 127:625–9.

    Article  PubMed  CAS  Google Scholar 

  40. Kalkoff KW, Macher E (1958) Über das Nachwachsen der Haare bei der Alopecia areata und maligna nach intracutaner Hydrocortisoninjektion. Hautarzt 9:441–51.

    PubMed  CAS  Google Scholar 

  41. Kurosawa M, Nakagawa S, Mizuashi M, Sasaki Y, Kawamura M, Saito M, Aiba S (2006) A comparison of the efficacy, relapse rate and side effects among three modalities of systemic corticosteroid therapy for alopecia areata. Dermatology 212:361–5.

    Article  PubMed  CAS  Google Scholar 

  42. Liakopoulou M, Alifieraki T, Katideniou A, Kakourou T, Tselalidou E, Tsiantis J, Stratigos J (1997) Children with alopecia areata: psychiatric symptomatology and life events. J Am Acad Child Adolesc Psychiatry 36:678–84.

    Article  PubMed  CAS  Google Scholar 

  43. Lu W, Shapiro J, Yu M, Barekatain A, Lo B, Finner A, McElwee K (2006) Alopecia areata: pathogenesis and potential for therapy. Expert Rev Mol Med 8:1–19.

    PubMed  Google Scholar 

  44. Macdonald Hull S, Cunliffe WJ (1991) Successful treatment of alopecia areata using the contact allergen diphencyprone. Br J Dermatol 124:212–13.

    Article  Google Scholar 

  45. Macdonald Hull S, Norris JF (1988) Diphencyprone in the treatment of long-standing alopecia areata. Br J Dermatol 119:367–74.

    Article  Google Scholar 

  46. Macdonald Hull S, Pepall L, Cunliffe WJ (1991) Alopecia areata in children: response to treatment with diphencyprone. Br J Dermatol 125:164–8.

    Article  Google Scholar 

  47. MacDonald Hull SP, Wood ML, Hutchinson PE, Sladden M, Messenger AG (2003) Guidelines for the management of alopecia areata. Br J Dermatol 149:692–99.

    Article  PubMed  CAS  Google Scholar 

  48. McElwee KJ, Boggess D, King LE Jr, Sundberg JP (1998) Experimental induction of alopecia areata-like hair loss in C3H/HeJ mice using full-thickness skin grafts. J Invest Dermatol 111:797–803.

    Article  PubMed  CAS  Google Scholar 

  49. McElwee KJ, Boggess D, Olivry T, Oliver RF, Whiting D, Tobin DJ, Bystryn JC, King LE Jr, Sundberg JP (1998) Comparison of alopecia areata in human and nonhuman mammalian species. Pathobiology 66:90–107.

    Article  PubMed  CAS  Google Scholar 

  50. McElwee KJ, Bristol IJ, Boggess D, Leiter EH, King LE Jr, Elson CO, Cong Y, Sundberg JP (1999) A common disease susceptibility gene locus for development of alopecia areata and/or colitis in C3H/HeJ mice. J Invest Dermatol Symp Proc 4:249.

    Article  Google Scholar 

  51. McElwee KJ, Tobin DJ, Bystryn JC, King LE Jr, Sundberg JP (1999) Alopecia areata: an autoimmune disease? Exp Dermatol 8:371–9.

    Article  PubMed  CAS  Google Scholar 

  52. McElwee K, Freyschmidt-Paul P, Ziegler A, Happle R, Hoffmann R (2001) Genetic susceptibility and severity of alopecia areata in human and animal models. Eur J Dermatol 11:11–16.

    PubMed  CAS  Google Scholar 

  53. McElwee KJ, Silva K, Beamer WG, King LE Jr, Sundberg JP (2001) Melanocyte and gonad activity as potential severity modifying factors in C3H/HeJ mouse alopecia areata. Exp Dermatol 10:420–9.

    Article  PubMed  CAS  Google Scholar 

  54. McElwee KJ, Freyschmidt-Paul P, Zoller M, Hoffmann R (2003) Alopecia areata susceptibility in rodent models. J Investig Dermatol Symp Proc 8:182–7.

    Article  PubMed  Google Scholar 

  55. McElwee KJ, Niiyama S, Freyschmidt-Paul P, Wenzel E, Kissling S, Sundberg JP, Hoffmann R (2003) Dietary soy oil content and soy-derived phytoestrogen genistein increase resistance to alopecia areata onset in C3H/HeJ mice. Exp Dermatol 12:30–6.

    Article  PubMed  CAS  Google Scholar 

  56. McElwee KJ, Freyschmidt-Paul P, Hoffmann R, Kissling S, Hummel S, Vitacolonna M, Zoller M (2005) Transfer of CD8(+) cells induces localized hair loss whereas CD4(+)/CD25(-) cells promote systemic alopecia areata and CD4(+)/CD25(+) cells blockade disease onset in the C3H/HeJ mouse model. J Invest Dermatol 124:947–57.

    Article  PubMed  CAS  Google Scholar 

  57. McElwee KJ, Yu M, Park SW, Ross EK, Finner A, Shapiro J (2005) What can we learn from animal models of Alopecia areata? Dermatology 211:47–53.

    Article  PubMed  Google Scholar 

  58. Micali G, Cicero RL, Nasca MR, Sapuppo A (1996) Treatment of alopecia areata with squaric acid dibutylester. Int J Dermatol 35:52–6.

    PubMed  CAS  Google Scholar 

  59. Michie HJ, Jahoda CA, Oliver RF, Johnson BE (1991) The DEBR rat: an animal model of human alopecia areata. Br J Dermatol 125:94–100.

    Article  PubMed  CAS  Google Scholar 

  60. Mo J, Zlotogorski A, Martinez-Mir A, Duvic M, Hordinsky M, Norris D, Price V, Nanova K, Gilliam TC, Londono D, Gordon D, Christiano AM (2007) A genome-wide scan maps a first susceptibility locus for alopecia areata to human chromosome 6q23.3 (in press)

    Google Scholar 

  61. Monk B (1989) Induction of hair growth in alopecia totalis with diphencyprone sensitization. Clin Exp Dermtol 14:154–7.

    Article  CAS  Google Scholar 

  62. Morling N, Frentz G, Fugger L, Georgsen J, Jakobsen B, Odum N, Svejgaard A (1991) DNA polymorphism of HLA class II genes in alopecia areata. Dis Markers 9:35–42.

    PubMed  CAS  Google Scholar 

  63. Muller SA, Winkelmann RK (1963) Alopecia areata: an evaluation of 736 patients. Arch Dermatol 88:290–7.

    PubMed  CAS  Google Scholar 

  64. Ochsendorf FR, Mitrou G, Milbradt R (1988) Therapie der Alopecia Areata mit Diphenylcyclopropenone. Z Hautkr 63:94–100.

    PubMed  CAS  Google Scholar 

  65. Orentreich N, Sturm HM, Weidman AI, Pelzig A (1960) Local injection of steroids and hair regrowth in alopecias. Arch Dermatol 82:894–902.

    PubMed  CAS  Google Scholar 

  66. Paus R (1996) Control of the hair cycle and hair diseases as cycling disorders. Curr Opin Dermatol 3:248–58.

    Google Scholar 

  67. Paus R, Nickoloff BJ, Ito T (2005) A “hairy” privilege. Trends Immunol 26:32–40.

    Article  PubMed  CAS  Google Scholar 

  68. Pforr J, Blaumeiser B, Becker T, Freudenberg-Hua Y, Hanneken S, Eigelshoven S, Cuyt I, De Weert J, Lambert J, Kruse R, Nothen MM, Betz RC (2006) Investigation of the p.Ser278Arg polymorphism of the autoimmune regulator (AIRE) gene in alopecia areata. Tissue Antigens 68(1):58–61.

    Article  PubMed  CAS  Google Scholar 

  69. Porter D, Burton JL (1971) A comparison of intra-lesional triamcinolone hexacetonide and triamcinolone acetonide in alopecia areata. Br J Dermatol 85:272.

    Article  PubMed  CAS  Google Scholar 

  70. Price V, Hordinsky M, Leonardi C, Roberts J, Olsen E, Rafal E, Korman N, Leung H, Garovoy M, Caro I, Whiting D (2006) Safety and efficacy results of a clinical study of efalizumab in patients with alopecia areata. J Invest Dermatol 126:105.

    Article  CAS  Google Scholar 

  71. Puavilai S, Puavilai G, Charuwichitratana S, Sakuntabhai A, Sriprachya-Anunt S (1994) Prevalence of thyroid diseases in patients with alopecia areata. Int J Dermatol 33:632–3.

    Article  PubMed  CAS  Google Scholar 

  72. Safavi KH, Muller SA, Suman VJ, Moshell AN, Melton LJ 3rd (1995) Incidence of alopecia areata in Olmsted County, Minnesota, 1975 through 1989. Mayo Clin Proc 70:628–33.

    PubMed  CAS  Google Scholar 

  73. Schuttelaar M-LA, Hamstra JJ, Plinck EP, Peereboom-Wynia JDR, Vuzevski VD, Mulder PGH, Oranje AP (1996) Alopecia areata in children: treatment with diphencyprone. Br J Dermatol 135:581–5.

    Article  PubMed  CAS  Google Scholar 

  74. Seiter S, Ugurel S, Tilgen W, Reinhold U (2001) Dermatology. High-dose pulse corticosteroid therapy in the treatment of severe alopecia areata. Dermatology 202:230–4.

    Article  PubMed  Google Scholar 

  75. Seyrafi H, Akhiani M, Abbasi H, Mirpour S, Gholamrezanezhad A (2005) Evaluation of the profile of alopecia areata and the prevalence of thyroid function test abnormalities and serum autoantibodies in Iranian patients. BMC Dermatol 31:5:11.

    Google Scholar 

  76. Sharma VK, Kumar B, Dawn G (1996) A clinical study of childhood alopecia areata in Chandigarh, India. Pediatr Dermatol 13:372–7.

    Article  PubMed  CAS  Google Scholar 

  77. Shellow WV, Edwards JE, Koo JY (1992) Profile of alopecia areata: a questionnaire analysis of patient and family. Int J Dermatol 31:186–9.

    Article  PubMed  CAS  Google Scholar 

  78. Stankler L (1979). Synchronous alopecia areata in two siblings: a possible viral aetiology. Lancet 1:1303–4.

    Article  PubMed  CAS  Google Scholar 

  79. Steen van der PHM, Baar van JMJ, Perret C, Happle R (1991) Treatment of alopecia areata with diphenylcyclopropenone. J Am Acad Dermatol 24:253–7.

    Google Scholar 

  80. Sundberg JP, Boggess D, Silva KA, McElwee KJ, King LE, Li R, Churchill G, Cox GA (2003) Major locus on mouse chromosome 17 and minor locus on chromosome 9 are linked with alopecia areata in C3H/HeJ mice. J Invest Dermatol 120(5):771–5.

    Article  PubMed  CAS  Google Scholar 

  81. Tan E, Tay YK, Goh CL, Chin Giam Y (2002). The pattern and profile of alopecia areata in Singapore – a study of 219 Asians. Int J Dermatol 41:748–53.

    Article  PubMed  Google Scholar 

  82. Tarlow JK, Clay FE, Cork MJ, Blakemore AI, McDonagh AJ, Messenger AG, Duff GW (1994) Severity of alopecia areata is associated with a polymorphism in the interleukin-1 receptor antagonist gene. J Invest Dermatol 103:387–90.

    Article  PubMed  CAS  Google Scholar 

  83. Tazi-Ahnini R, Cork MJ, Gawkrodger DJ, Birch MP, Wengraf D, McDonagh AJ, Messenger AG (2002) Role of the autoimmune regulator (AIRE) gene in alopecia areata: strong association of a potentially functional AIRE polymorphism with alopecia universalis. Tissue Antigens 60(6):489–95.

    Article  PubMed  CAS  Google Scholar 

  84. Tobin DJ (2003) Characterization of hair follicle antigens targeted by the anti-hair follicle immune response. J Investig Dermatol Symp Proc 8:176–81.

    Article  PubMed  CAS  Google Scholar 

  85. Tosti A, Iorizzo M, Botta GL, Milani M (2006) Efficacy and safety of a new clobetasol propionate 0.05% foam in alopecia areata: a randomized, double-blind placebo-controlled trial. JEADV 20:1243–47.

    PubMed  Google Scholar 

  86. Tosti A, Piraccini BM, Pazzaglia M, Vincenzi C (2003) Clobetasol propionate 0.05% under occlusion in the treatment of alopecia totalis/universalis J Am Acad Dermatol 49:96–8.

    Article  PubMed  Google Scholar 

  87. Valsecchi R, Vicari O, Frigeni A, Foiadelli L, Naldi L, Cainelli T (1985) Familial alopecia areata-genetic susceptibility or coincidence? Acta Derm Venereol 65:175–7.

    PubMed  CAS  Google Scholar 

  88. Van der Steen P, Traupe H, Happle R, Boezeman J, Strater R, Hamm H (1992) The genetic risk for alopecia areata in first degree relatives of severely affected patients. Acta Derm Venereol (Stockh) 72:373–5.

    Google Scholar 

  89. Weise K, Kretzschmar L, John SM, Hamm H (1996) Topical immunotherapy in alopecia areata: anamnestic and clinical criteria of prognostic significance. Dermatology 192:129–33.

    Article  PubMed  CAS  Google Scholar 

  90. Whiting DA (2003) Histopathologic features of alopecia areata: a new look. Arch Dermatol 139:1555–9.

    Article  PubMed  Google Scholar 

  91. Wiseman MC, Shapiro J, MacDonald N, Lui H (2001) Predictive model for immunotherapy of alopecia areata with diphencyprone. Arch Dermatol 137:1063–8.

    PubMed  CAS  Google Scholar 

  92. Wunderlich C, Braun-Falco O (1965) Mongolismus und Alopecia areata. Med Welt 10:477–81.

    PubMed  CAS  Google Scholar 

  93. Yang S, Yang J, Liu JB, Wang HY, Yang Q, Gao M, Liang YH, Lin GS, Lin D, Hu XL, Fan L, Zhang XJ (2004) The genetic epidemiology of alopecia areata in china. Br J Dermatol 151:16–23.

    Article  PubMed  CAS  Google Scholar 

  94. Zakaria W, Passeron T, Ostovari N, Lacour JP, Ortonne JP (2004) 308-nm excimer laser therapy in alopecia areata. J Am Acad Dermatol 51:837–8.

    Article  PubMed  Google Scholar 

  95. Zlotogorski A, Weinrauch L, Brautbar C (1990) Familial alopecia areata: no linkage with HLA. Tissue Antigens 36:40–1.

    Article  PubMed  CAS  Google Scholar 

  96. Zöller M, McElwee KJ, Engel P, Hoffmann R (2002) Transient CD44 variant isoform expression and reduction in CD4(+)/CD25(+) regulatory T cells in C3H/HeJ mice with alopecia areata. J Invest Dermatol 118:983–92.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Schimmelpfengstr. 4, 34613, Schwalmstadt, Germany

    Pia Freyschmidt-Paul

  2. Kaiser-Joseph-Str. 262, 79098, Freiburg, Germany

    Rolf Hoffmann

  3. Division of Dermatology, University of British Columbia, 835 West 10th Avenue, Vancouver B.C., Canada

    Kevin J. McElwee

Authors
  1. Pia Freyschmidt-Paul
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Rolf Hoffmann
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Kevin J. McElwee
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Clinical Research Center for Hair and Skin Physiology (CRC), Charité -Universitätsmedizin Berlin, Charitéplatz 1, 11017 , Berlin, Germany

    Ulrike Blume-Peytavi

  2. Department of Dermatology, University of Bologna, Via Massarenti, 1, 40138 , Bologna, Italy

    Antonella Tosti

  3. Department of Dermatology, University Hospital of Zürich, Gloriastrasse 31, 8091 , Zürich, Switzerland

    Ralph M. Trüeb

Rights and permissions

Reprints and permissions

Copyright information

© 2008 Springer London

About this chapter

Cite this chapter

Freyschmidt-Paul, P., Hoffmann, R., McElwee, K. (2008). Alopecia Areata. In: Blume-Peytavi, U., Tosti, A., Trüeb, R. (eds) Hair Growth and Disorders. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-46911-7_15

Download citation

  • DOI: https://doi.org/10.1007/978-3-540-46911-7_15

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-46908-7

  • Online ISBN: 978-3-540-46911-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation